Vaxzevria: AstraZeneca zieht Coronaimpfstoff zurück
Der Coronaimpfstoff von AstraZeneca ist nicht mehr in der EU zugelassen. Das Unternehmen beantragte die Rücknahme der Zulassung selbst.
Read more at ZEIT ONLINE
Astrazeneca-Impfstoff gegen Corona wegen schwacher Nachfrage ...
Der Corona-Impfstoff des schwedisch-britischen Pharmaunternehmens Astrazeneca, Vaxzevria, ist nicht mehr in der EU zugelassen. Die bereits im März beschlossene ...
Read more at FAZ - Frankfurter Allgemeine Zeitung
AstraZeneca - 10 things to know with detail
AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company that was formed in 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the United Kingdom.
The company's headquarters are located in Cambridge, England, and it has a global presence with operations in over 100 countries.
AstraZeneca focuses on the discovery, development, and commercialization of innovative medicines in areas such as oncology, cardiovascular, respiratory, and autoimmune diseases.
Some of AstraZeneca's most well-known products include the cancer drugs Tagrisso and Lynparza, the respiratory medication Symbicort, and the cholesterol-lowering drug Crestor.
AstraZeneca has a strong pipeline of new drugs in development, with a particular emphasis on immuno-oncology and personalized medicine.
The company has been actively involved in the fight against COVID-19, developing a vaccine in partnership with the University of Oxford that has been authorized for emergency use in various countries.
AstraZeneca is committed to sustainability and corporate responsibility, with initiatives focused on environmental stewardship, social impact, and ethical business practices.
The company invests heavily in research and development, with a significant portion of its revenue dedicated to advancing scientific innovation and drug discovery.
AstraZeneca has a diverse workforce of over 70,000 employees worldwide, including scientists, researchers, sales and marketing professionals, and support staff.
In recent years, AstraZeneca has received numerous awards and accolades for its innovative products, commitment to patient care, and contributions to the pharmaceutical industry.